Jack A. Khattar, President, CEO at SUPERNUS PHARMACEUTICALS, INC. (SUPN), sold 30,720 shares at $38.02 ($1.2M) on 2022-12-20, disclosed to the SEC on 2022-12-22.
Open-market sale of $1.2M SUPN by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.02 | 4,006 | $152K | 13.0% |
| 2 | $38.02 | 4,006 | $152K | 13.0% |
| 3 | $38.14 | 11,354 | $433K | 37.0% |
| 4 | $38.14 | 11,354 | $433K | 37.0% |
| Total | $38.11 avg | 30,720 | $1.2M | 100% |
| Filing → |
| SUPN | SELL | 2025-10-03 | $183K | — | Filing → |
| SUPN | SELL | 2025-10-02 | $3.9M | — | Filing → |
| SUPN | SELL | 2025-10-01 | $414K | — | Filing → |